InterWest Partners

InterWest Partners, founded in 1979 and based in San Francisco, California, is a venture capital firm that focuses on investing in the healthcare and information technology sectors in North America. The firm typically invests between $7 million and $15 million throughout the course of its engagement with portfolio companies, which may include multiple rounds of financing. While InterWest generally targets early-stage companies, it evaluates investment opportunities based on their individual merits rather than strictly adhering to a specific stage of development. The firm's investment interests encompass a range of areas, including semiconductors, software, computer hardware, healthcare devices and supplies, and manufacturing.

Doug Fisher

Partner

Charline Gauthier

Venture Partner

Flip Gianos

Managing Partner

Max Kim

Associate

Gil Kliman

Managing Partner

Gilbert Kliman

Managing Partner

Khaled Nasr

General Partner and COO

Arnie Oronsky

Managing Partner

Karen Wilson

CFO

421 past transactions

GoCheck

Venture Round in 2021
GoCheck, also known as Gobiquity, Inc., specializes in mobile health applications aimed at the early detection and prevention of health disorders, particularly eye diseases. Its flagship product, GoCheck Kids, is a smartphone application designed to screen for amblyopia risk factors in children, adhering to the guidelines set by the American Association for Pediatric Ophthalmology and Strabismus. The application enables pediatric teams to conduct visual acuity assessments and photo screenings, significantly enhancing early detection efforts. GoCheck Kids is utilized by over 6,500 pediatric teams across the United States and Europe, addressing the urgent need to prevent vision impairment, a leading disabling condition in children. By leveraging the manufacturing scale of smartphones, GoCheck has made early vision screening more affordable, reducing costs by over 60%. The company, founded in 2010 and based in Aliso Viejo, California, is FDA-registered and CE certified, reflecting its commitment to quality and safety in pediatric health care.

PMV Pharmaceuticals

Series C in 2019
PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

GoCheck

Series B in 2019
GoCheck, also known as Gobiquity, Inc., specializes in mobile health applications aimed at the early detection and prevention of health disorders, particularly eye diseases. Its flagship product, GoCheck Kids, is a smartphone application designed to screen for amblyopia risk factors in children, adhering to the guidelines set by the American Association for Pediatric Ophthalmology and Strabismus. The application enables pediatric teams to conduct visual acuity assessments and photo screenings, significantly enhancing early detection efforts. GoCheck Kids is utilized by over 6,500 pediatric teams across the United States and Europe, addressing the urgent need to prevent vision impairment, a leading disabling condition in children. By leveraging the manufacturing scale of smartphones, GoCheck has made early vision screening more affordable, reducing costs by over 60%. The company, founded in 2010 and based in Aliso Viejo, California, is FDA-registered and CE certified, reflecting its commitment to quality and safety in pediatric health care.

Splice Machine

Venture Round in 2019
Splice Machine is a data platform that offers offline, and batch analysis, and powers intelligent applications for operational workflows. Splice Machine is disrupting the $30 billion traditional database world with the open-source dual-engine RDBMS for mixed operational and analytical workloads, powered by Apache Hadoop and Apache Spark. The Splice Machine RDBMS executes operational workloads on Apache HBase® and analytical workloads on Apache Spark. Splice Machine makes it easy to develop and create modern, real-time, scalable applications, or to offload operational and analytical workloads from expensive Oracle, Teradata, and Netezza systems. Typical use cases are ETL, operational reporting, or real-time applications.

Aria Systems

Private Equity Round in 2018
Proven by the world's most demanding enterprises, including AAA NCNU, Constant Contact, Falck, Hootsuite, Pitney Bowes, Audi, Adobe, Telekom Denmark, Philips, Roku, and VMware, Aria helps enterprises grow their recurring revenue businesses. Aria helps clients take advantage of each customer-driven event − known as revenue moments − with agile billing, active customer engagement, and the rapid development of new products and services. With Aria's end-to-end active monetization platform, global brands can get to market faster with a wider variety of products and services, while maximizing customer satisfaction, retention, and lifetime value.

The RealReal

Series G in 2018
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Avedro

Series F in 2018
Avedro, Inc. is an ophthalmic pharmaceutical and medical device company that specializes in developing and commercializing products for treating corneal disorders, particularly those associated with corneal weakness. The company's primary offering is the Avedro Corneal Remodeling platform, which includes the KXL and Mosaic systems, designed to deliver ultraviolet A (UVA) light alongside various single-use riboflavin drug formulations. This platform addresses corneal ectatic disorders and refractive conditions, with specific applications in treating progressive keratoconus and corneal ectasia following refractive surgery. Avedro also offers the Keraflex procedure, a non-invasive technique for corneal reshaping that preserves corneal integrity. The company's products are primarily marketed to ophthalmologists, hospitals, and ambulatory surgery centers both in the United States and internationally through a network of distributors. Avedro, which was incorporated in 2002 and is headquartered in Waltham, Massachusetts, operates as a subsidiary of Glaukos Corporation.

Totango

Series D in 2018
Totango, Inc. is a company that specializes in developing an enterprise-grade customer success platform aimed at enhancing customer engagement and loyalty. Founded in 2010 and headquartered in Redwood City, California, Totango's platform allows businesses to consolidate customer data, monitor changes in customer health, and engage proactively with clients. Its offerings include the Customer Success Centre for enhancing engagement, Zoe for measuring enterprise impact, and DNA-CX for real-time customer context. The solutions address various aspects of customer success, including onboarding, adoption, renewal, and escalation. By simplifying the complexities of managing customer relationships, Totango helps companies increase customer lifetime value and drive predictable revenue growth. Totango operates as a subsidiary of Totango Ltd.

Gynesonics

Private Equity Round in 2018
Gynesonics, Inc. is a healthcare company specializing in the development of minimally invasive solutions for symptomatic uterine fibroids in women. The company offers the Sonata System, which utilizes sonography-guided transcervical fibroid ablation to treat these conditions under intrauterine sonography guidance. Founded in 2005, Gynesonics is headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands. The company serves customers worldwide, focusing on providing advanced, incision-free treatment options for uterine conditions.

Centrexion Therapeutics

Series D in 2018
Centrexion Therapeutics Corporation is a late clinical-stage biopharmaceutical company dedicated to developing novel, non-opioid, and non-addictive therapies for chronic pain management. Founded in 2013 and based in Boston, Massachusetts, the company’s product pipeline includes CNTX-4975, currently undergoing Phase III trials for knee osteoarthritis pain and Phase II trials for Morton’s neuroma and canine osteoarthritis. Additionally, CNTX-0290 is in Phase I trials for various chronic pain conditions, while CNTX-6970 targets inflammatory pain and CNTX-2022, a high-concentration topical gel formulation of lidocaine, is also in Phase I trials for superficial musculoskeletal pain and related conditions. Furthermore, CNTX-6016 is a pre-clinical candidate aimed at treating chronic neuropathic pain. Centrexion Therapeutics is committed to addressing the unmet medical needs in chronic pain treatment by focusing on safety and efficacy.

Splice Machine

Series B in 2017
Splice Machine is a data platform that offers offline, and batch analysis, and powers intelligent applications for operational workflows. Splice Machine is disrupting the $30 billion traditional database world with the open-source dual-engine RDBMS for mixed operational and analytical workloads, powered by Apache Hadoop and Apache Spark. The Splice Machine RDBMS executes operational workloads on Apache HBase® and analytical workloads on Apache Spark. Splice Machine makes it easy to develop and create modern, real-time, scalable applications, or to offload operational and analytical workloads from expensive Oracle, Teradata, and Netezza systems. Typical use cases are ETL, operational reporting, or real-time applications.

Achates Power

Series D in 2017
Achates Power, Inc. is a company based in San Diego, California, specializing in the development, manufacturing, and marketing of internal combustion engines for various industries, including commercial trucks, passenger vehicles, military, maritime, and stationary power sectors. Founded in 2004, the company focuses on opposed-piston, two-stroke, and compression ignition engines designed to enhance fuel efficiency and reduce greenhouse gas emissions. Achates Power's engines utilize existing fuel infrastructure, allowing global equipment manufacturers to meet fuel efficiency and emissions standards without incurring additional costs or complexity. The company also offers engineering services, assisting clients in engine design and providing technology licenses for access to proprietary designs, tools, and patents. Its experienced team employs advanced testing, simulation, and analysis techniques to further innovate in the field of combustion engine technology.

Aria Systems

Series F in 2017
Proven by the world's most demanding enterprises, including AAA NCNU, Constant Contact, Falck, Hootsuite, Pitney Bowes, Audi, Adobe, Telekom Denmark, Philips, Roku, and VMware, Aria helps enterprises grow their recurring revenue businesses. Aria helps clients take advantage of each customer-driven event − known as revenue moments − with agile billing, active customer engagement, and the rapid development of new products and services. With Aria's end-to-end active monetization platform, global brands can get to market faster with a wider variety of products and services, while maximizing customer satisfaction, retention, and lifetime value.

Braze

Series D in 2017
Braze is a comprehensive customer engagement platform that powers relevant and memorable experiences between consumers and the brands they love. Context underpins every Braze interaction, helping brands foster human connection with consumers through interactive conversations across channels that deliver value quickly and continuously. The company was named a Leader in the 2019 Gartner Magic Quadrant for Mobile Marketing Platforms and was recognized as one of Inc Magazine's 2019 Best Workplaces. Braze is headquartered in New York with offices in Chicago, London, San Francisco, and Singapore. Learn more at braze.com.

Neuronetics

Series G in 2017
Neuronetics is a medical technology company based in Malvern, Pennsylvania, established in 2003. It specializes in developing non-invasive therapies for psychiatric and neurological disorders, particularly Major Depressive Disorder (MDD). The company's flagship product, the NeuroStar Advanced Therapy System, utilizes transcranial magnetic stimulation (TMS) to deliver MRI-strength magnetic pulses that induce electrical currents in targeted areas of the brain associated with mood regulation. This innovative treatment is the first of its kind to receive FDA clearance for patients who have not found relief from traditional antidepressant therapies. Neuronetics aims to improve the quality of life for individuals suffering from mental health conditions through its advanced, non-systemic treatment options.

Avedro

Venture Round in 2017
Avedro, Inc. is an ophthalmic pharmaceutical and medical device company that specializes in developing and commercializing products for treating corneal disorders, particularly those associated with corneal weakness. The company's primary offering is the Avedro Corneal Remodeling platform, which includes the KXL and Mosaic systems, designed to deliver ultraviolet A (UVA) light alongside various single-use riboflavin drug formulations. This platform addresses corneal ectatic disorders and refractive conditions, with specific applications in treating progressive keratoconus and corneal ectasia following refractive surgery. Avedro also offers the Keraflex procedure, a non-invasive technique for corneal reshaping that preserves corneal integrity. The company's products are primarily marketed to ophthalmologists, hospitals, and ambulatory surgery centers both in the United States and internationally through a network of distributors. Avedro, which was incorporated in 2002 and is headquartered in Waltham, Massachusetts, operates as a subsidiary of Glaukos Corporation.

PMV Pharmaceuticals

Series B in 2017
PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

Vidora

Seed Round in 2017
Vidora’s mission is to enhance the performance of Marketing and Product teams with No-Code Machine Learning. Our Machine Learning Platform, Cortex, allows teams to use predictions to continually optimize conversions and engagement, while providing end-to-end automation, allowing teams to create hundreds of predictions without the risk and cost of building in house. The largest global brands like Walmart, News Corp, and Discovery, leverage Cortex to intelligently learn from continuous streams of raw data to drive higher performance and automation across the enterprise.

Centrexion Therapeutics

Series C in 2016
Centrexion Therapeutics Corporation is a late clinical-stage biopharmaceutical company dedicated to developing novel, non-opioid, and non-addictive therapies for chronic pain management. Founded in 2013 and based in Boston, Massachusetts, the company’s product pipeline includes CNTX-4975, currently undergoing Phase III trials for knee osteoarthritis pain and Phase II trials for Morton’s neuroma and canine osteoarthritis. Additionally, CNTX-0290 is in Phase I trials for various chronic pain conditions, while CNTX-6970 targets inflammatory pain and CNTX-2022, a high-concentration topical gel formulation of lidocaine, is also in Phase I trials for superficial musculoskeletal pain and related conditions. Furthermore, CNTX-6016 is a pre-clinical candidate aimed at treating chronic neuropathic pain. Centrexion Therapeutics is committed to addressing the unmet medical needs in chronic pain treatment by focusing on safety and efficacy.

Integrated Diagnostics

Series C in 2016
The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer's through blood tests that can monitor tens to hundreds of disease markers simultaneously. The company plans to develop a pipeline of game-changing diagnostic products that enable the diagnosis and prognosis of a variety of diseases. The company is based on the concept of a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes and other molecules.

Restoration Robotics

Venture Round in 2016
Restoration Robotics is a privately held medical device company focused on advancing hair transplantation technology. The company has developed the ARTAS™ System, an innovative image-guided platform that facilitates follicular unit extraction. This system is notable for being the only computer-assisted, physician-controlled robotic solution for harvesting hair follicles, which enhances the precision and efficiency of the hair restoration process. By combining cutting-edge robotics with medical expertise, Restoration Robotics aims to improve outcomes for patients seeking hair restoration solutions.

Grokker

Series B in 2016
Grokker Inc. operates an online fitness training platform that offers a comprehensive range of videos focused on fitness, yoga, and cooking. Founded in 2012 and based in San Jose, California, the platform allows users to access thousands of instructional videos taught by experts in various disciplines, including cooking styles from around the world, yoga practices for different needs, and various fitness regimens. Grokker emphasizes a holistic approach to workplace wellness, providing an extensive library of over 3,700 videos that cover exercise, mindfulness, nutrition, finance, and sleep. With contributions from more than 130 master experts, Grokker aims to foster a supportive community that enhances employee well-being and engagement across various locations.

ReVision Optics

Venture Round in 2016
ReVision Optics, Inc. designs, manufactures, and delivers implantable products for the treatment of presbyopia. It offers PRESBYLENS Corneal Inlay, a refractive surgery solution to correct vision lost by the natural aging process called presbyopia. The company serves the ophthalmology professionals. ReVision Optics, Inc. was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in 2005. The company was founded in 1996 and is based in Lake Forest, California.

Cheetah Digital

Series A in 2016
Cheetah Digital is a provider of cross-channel customer engagement solutions tailored for modern marketers. The company offers a Customer Engagement Suite that empowers enterprise brands to enhance revenue, foster enduring customer relationships, and facilitate unique value exchanges throughout the customer lifecycle. Cheetah Digital's platform allows marketers to create personalized experiences, implement cross-channel messaging, and develop loyalty strategies, all supported by an engagement data platform designed to adapt to the evolving needs of today's consumers. By focusing on marketers rather than IT-centric approaches, Cheetah Digital positions itself as a leader in delivering effective marketing solutions.

Welltok

Series E in 2016
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, that specializes in consumer activation within the healthcare sector. Founded in 2009, Welltok provides a health optimization platform that connects health plans, employers, providers, and public entities with consumers by offering personalized guidance and incentives for health improvement. The platform utilizes a large consumer database and machine learning to enhance audience engagement in healthy activities. By facilitating targeted actions, Welltok enables organizations to foster meaningful connections with individuals, encouraging them to take purposeful steps towards optimizing their health and wellbeing.

Restoration Robotics

Venture Round in 2016
Restoration Robotics is a privately held medical device company focused on advancing hair transplantation technology. The company has developed the ARTAS™ System, an innovative image-guided platform that facilitates follicular unit extraction. This system is notable for being the only computer-assisted, physician-controlled robotic solution for harvesting hair follicles, which enhances the precision and efficiency of the hair restoration process. By combining cutting-edge robotics with medical expertise, Restoration Robotics aims to improve outcomes for patients seeking hair restoration solutions.

Totango

Series C in 2016
Totango, Inc. is a company that specializes in developing an enterprise-grade customer success platform aimed at enhancing customer engagement and loyalty. Founded in 2010 and headquartered in Redwood City, California, Totango's platform allows businesses to consolidate customer data, monitor changes in customer health, and engage proactively with clients. Its offerings include the Customer Success Centre for enhancing engagement, Zoe for measuring enterprise impact, and DNA-CX for real-time customer context. The solutions address various aspects of customer success, including onboarding, adoption, renewal, and escalation. By simplifying the complexities of managing customer relationships, Totango helps companies increase customer lifetime value and drive predictable revenue growth. Totango operates as a subsidiary of Totango Ltd.

Stellar Loyalty

Venture Round in 2016
Stellar Loyalty Inc. specializes in providing cloud-based customer loyalty and engagement solutions. Founded in 2014 and headquartered in Foster City, California, with additional offices in Manila, Philippines, Stellar Loyalty integrates mobile and big data technologies to enhance customer interactions. The company’s platform enables brands to recognize, engage, and reward loyal customers by connecting loyalty programs with point-of-sale, marketing, and customer relationship management systems. Their offerings include advanced features such as calculations, business rules, segmentations, and predictive analytics, which together facilitate a seamless experience across digital, physical, and human interactions. Stellar Loyalty aims to enhance consumer experiences by delivering personalized value and recognition to customers. The company was acquired by Cheetah Digital in 2018.

C3 AI

Series D in 2016
C3.ai, Inc. is an enterprise artificial intelligence software company that specializes in providing software-as-a-service applications designed to facilitate digital transformation for businesses. The company's primary offering, the C3 AI Suite, serves as a platform for developing, deploying, and operating large-scale AI applications and predictive analytics at an accelerated pace. C3.ai's portfolio includes a range of industry-specific applications, such as solutions for inventory optimization, supply chain risk management, customer churn management, production scheduling, predictive maintenance, and fraud detection. These applications cater to diverse sectors, including oil and gas, manufacturing, banking, healthcare, and telecommunications. C3.ai has established strategic partnerships with key players in various markets to enhance its offerings. Headquartered in Redwood City, California, the company has been operational since 2009 and primarily serves customers across Europe, Asia, and the United States.

Restoration Robotics

Venture Round in 2016
Restoration Robotics is a privately held medical device company focused on advancing hair transplantation technology. The company has developed the ARTAS™ System, an innovative image-guided platform that facilitates follicular unit extraction. This system is notable for being the only computer-assisted, physician-controlled robotic solution for harvesting hair follicles, which enhances the precision and efficiency of the hair restoration process. By combining cutting-edge robotics with medical expertise, Restoration Robotics aims to improve outcomes for patients seeking hair restoration solutions.

GoCheck

Series B in 2016
GoCheck, also known as Gobiquity, Inc., specializes in mobile health applications aimed at the early detection and prevention of health disorders, particularly eye diseases. Its flagship product, GoCheck Kids, is a smartphone application designed to screen for amblyopia risk factors in children, adhering to the guidelines set by the American Association for Pediatric Ophthalmology and Strabismus. The application enables pediatric teams to conduct visual acuity assessments and photo screenings, significantly enhancing early detection efforts. GoCheck Kids is utilized by over 6,500 pediatric teams across the United States and Europe, addressing the urgent need to prevent vision impairment, a leading disabling condition in children. By leveraging the manufacturing scale of smartphones, GoCheck has made early vision screening more affordable, reducing costs by over 60%. The company, founded in 2010 and based in Aliso Viejo, California, is FDA-registered and CE certified, reflecting its commitment to quality and safety in pediatric health care.

Wiser Solutions

Venture Round in 2016
Wiser is the leading provider of actionable data for better decisions. Wiser collects and analyzes online and in-store data with unmatched speed, scale and accuracy. The Wiser platform then blends these insights with advanced workflow software to drive business value for brands and retailers. Using a unique combination of data science and human validation, Wiser offers integrated solutions for every aspect of retail, all in one place.

Khoros

Series F in 2016
Khoros is a software company that specializes in customer engagement solutions, providing a centralized cloud-based platform designed to enhance digital customer experiences. Its platform allows businesses to manage social media, monitor customer interactions, and scale their social marketing and customer service efforts. By facilitating millions of conversations, Khoros helps brands make informed decisions through data insights. The company aims to turn isolated knowledge into valuable enterprise insights, fostering stronger connections between businesses and their customers while anticipating customer needs to drive sales, loyalty, and innovation.

Spredfast

Series F in 2016
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Braze

Series C in 2016
Braze is a comprehensive customer engagement platform that powers relevant and memorable experiences between consumers and the brands they love. Context underpins every Braze interaction, helping brands foster human connection with consumers through interactive conversations across channels that deliver value quickly and continuously. The company was named a Leader in the 2019 Gartner Magic Quadrant for Mobile Marketing Platforms and was recognized as one of Inc Magazine's 2019 Best Workplaces. Braze is headquartered in New York with offices in Chicago, London, San Francisco, and Singapore. Learn more at braze.com.

Obalon Therapeutics

Series E in 2016
Obalon Therapeutics, Inc. is a medical device company headquartered in Carlsbad, California, specializing in the development and commercialization of innovative devices for obesity treatment. The company is known for its Obalon Balloon System, which features a swallowable capsule containing an inflatable balloon that aids in weight loss for individuals with obesity. This system includes the Obalon Navigation System, a console that uses hardware and software to track the balloon's placement, and the Obalon Touch Inflation Dispenser, a semi-automated device for inflating the balloon after placement. Additionally, it provides a disposable canister filled with gas for inflation. Founded in 2008, Obalon has established itself as a leader in gastric balloon technology, emphasizing collaboration with clinicians to enhance treatment outcomes while prioritizing safety and performance. As of early 2020, the company operated three retail treatment centers in California.

The RealReal

Series E in 2016
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Eiger BioPharmaceuticals

Debt Financing in 2016
Eiger BioPharmaceuticals is a late-stage biopharmaceutical company based in Palo Alto, California, dedicated to developing targeted therapies for rare and ultra-rare diseases. The company’s lead product candidate, Lonafarnib, is an orally bioavailable small molecule currently undergoing Phase 3 clinical trials for the treatment of hepatitis delta virus (HDV) infection. Eiger's pipeline also includes Lambda, which is in Phase 2 trials and targets type III interferon receptors for HDV, as well as Lonafarnib for progeria and progeroid laminopathies. Additionally, the company is developing Avexitide, which has completed Phase 2 trials for post-bariatric hypoglycemia and is also in Phase 2 for congenital hyperinsulinism. Eiger's focus is on addressing high unmet medical needs in serious diseases where no approved therapies currently exist.

Potenza Therapeutics

Venture Round in 2016
Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2014. The company focuses on developing a portfolio of oncology programs that harness the body's immune system to identify and eliminate tumors. Potenza's innovative approach is rooted in understanding the biological mechanisms by which cancer cells evade immune detection and destruction. By leveraging these insights, the company aims to create effective pharmaceuticals that enhance the health outcomes of cancer patients.

Bigstep

Seed Round in 2016
Bigstep is a cloud provider that specializes in making professional analytics solutions accessible to businesses of all sizes. Founded in 2013 by Lucas Roh, the company is headquartered in London and operates data infrastructure in the U.K. and Germany. Bigstep's platform features bare metal cloud technology, which is designed to optimize performance and reduce latency for demanding workloads. It offers a production-ready big data environment that can be set up quickly, along with scalable storage, high-speed networking, and enhanced security features. By utilizing advanced technologies and automation, Bigstep enables clients to achieve improved efficiency in both cost and performance.

Tesaro

Post in 2016
TESARO, Inc. is an oncology-focused biopharmaceutical company established in 2010 and based in Waltham, Massachusetts. The company specializes in the identification, acquisition, development, and commercialization of cancer therapeutics and supportive care products. Its notable offerings include ZEJULA, an oral poly polymerase inhibitor used for the maintenance treatment of recurrent ovarian cancer, and VARUBI, a neurokinin-1 receptor antagonist designed to prevent chemotherapy-induced nausea and vomiting. TESARO is also advancing a range of immunotherapy candidates, such as TSR-042, TSR-022, and TSR-033, all currently in phase I clinical trials. The company has formed various collaboration and licensing agreements with industry partners, including AnaptysBio, Janssen Biotech, and Genentech. In January 2019, TESARO became a subsidiary of GlaxoSmithKline plc, further enhancing its capabilities in cancer treatment innovation.

Tizona Therapeutics

Series B in 2016
Tizona Therapeutics, Inc. is an immunotherapy company focused on developing treatments for cancer and autoimmune diseases. Founded in 2014 and located in South San Francisco, California, the company is known for its innovative products, including an Anti-CCR4 antibody aimed at cancer treatment, as well as IL-35 antagonists and agonists that target immune response modulation. Tizona is actively collaborating with its scientific founders to enhance understanding of the role of regulatory T cells in tumor immunosuppression, which is crucial for developing effective therapies. By targeting specific cell types and biological mechanisms responsible for immune suppression in the tumor microenvironment, Tizona aims to provide patients with durable and complete remissions from their conditions.

Aria Systems

Series E in 2016
Proven by the world's most demanding enterprises, including AAA NCNU, Constant Contact, Falck, Hootsuite, Pitney Bowes, Audi, Adobe, Telekom Denmark, Philips, Roku, and VMware, Aria helps enterprises grow their recurring revenue businesses. Aria helps clients take advantage of each customer-driven event − known as revenue moments − with agile billing, active customer engagement, and the rapid development of new products and services. With Aria's end-to-end active monetization platform, global brands can get to market faster with a wider variety of products and services, while maximizing customer satisfaction, retention, and lifetime value.

Stellar Loyalty

Series A in 2016
Stellar Loyalty Inc. specializes in providing cloud-based customer loyalty and engagement solutions. Founded in 2014 and headquartered in Foster City, California, with additional offices in Manila, Philippines, Stellar Loyalty integrates mobile and big data technologies to enhance customer interactions. The company’s platform enables brands to recognize, engage, and reward loyal customers by connecting loyalty programs with point-of-sale, marketing, and customer relationship management systems. Their offerings include advanced features such as calculations, business rules, segmentations, and predictive analytics, which together facilitate a seamless experience across digital, physical, and human interactions. Stellar Loyalty aims to enhance consumer experiences by delivering personalized value and recognition to customers. The company was acquired by Cheetah Digital in 2018.

Tizona Therapeutics

Series A in 2016
Tizona Therapeutics, Inc. is an immunotherapy company focused on developing treatments for cancer and autoimmune diseases. Founded in 2014 and located in South San Francisco, California, the company is known for its innovative products, including an Anti-CCR4 antibody aimed at cancer treatment, as well as IL-35 antagonists and agonists that target immune response modulation. Tizona is actively collaborating with its scientific founders to enhance understanding of the role of regulatory T cells in tumor immunosuppression, which is crucial for developing effective therapies. By targeting specific cell types and biological mechanisms responsible for immune suppression in the tumor microenvironment, Tizona aims to provide patients with durable and complete remissions from their conditions.

Benvenue Medical

Series F in 2016
Benvenue Medical, Inc. specializes in the design, manufacturing, and marketing of minimally invasive expandable implant systems for treating spinal disorders, specifically vertebral compression fractures and degenerative disc diseases. The company offers products such as the Kiva system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer – C system, aimed at treating various types of pathological vertebral compression fractures. Additionally, Benvenue Medical has introduced the Luna 3D, an expandable interbody fusion system designed for use in minimally invasive, mini-open, or open surgical procedures. Established in 2004 and headquartered in Santa Clara, California, the company serves a diverse customer base in the United States, Canada, Belgium, France, and Germany.

Crowdpac

Series A in 2016
Crowdpac, Inc. is a non-partisan political technology company that provides an online platform aimed at enhancing political participation in the United States. Founded in 2013 and based in Palo Alto, California, Crowdpac compiles essential information about political candidates, including their funding sources, positions on key issues, voting behavior, and past activities, into accessible candidate pages. Users can explore various issues such as healthcare, immigration, gender equality, and environmental policies, allowing them to find and support candidates that align with their priorities. Additionally, Crowdpac offers crowdfunding tools to empower candidates, organizations, and citizens to raise funds for political initiatives without relying on large donors or special interests. As of November 2019, Crowdpac operates as a subsidiary of Prytany.

Triposo

Venture Round in 2015
Triposo, Inc. develops interactive travel guides for the mobile devices. It offers country maps, and language and city guides. The company also provides background information on the country, culture, and history; descriptions; list of restaurants, bars, and nightclubs; hiking, biking, or relaxing activities information; and offline maps. Triposo, Inc. was founded in 2010 and is based in Amersfoort, the Netherlands. As of October 10, 2017, Triposo, Inc. operates as a subsidiary of Musement S.r.l.

Celladon

Post in 2015
Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. Celladon was founded in 2000 and is based in La Jolla, California.

Avedro

Series E in 2015
Avedro, Inc. is an ophthalmic pharmaceutical and medical device company that specializes in developing and commercializing products for treating corneal disorders, particularly those associated with corneal weakness. The company's primary offering is the Avedro Corneal Remodeling platform, which includes the KXL and Mosaic systems, designed to deliver ultraviolet A (UVA) light alongside various single-use riboflavin drug formulations. This platform addresses corneal ectatic disorders and refractive conditions, with specific applications in treating progressive keratoconus and corneal ectasia following refractive surgery. Avedro also offers the Keraflex procedure, a non-invasive technique for corneal reshaping that preserves corneal integrity. The company's products are primarily marketed to ophthalmologists, hospitals, and ambulatory surgery centers both in the United States and internationally through a network of distributors. Avedro, which was incorporated in 2002 and is headquartered in Waltham, Massachusetts, operates as a subsidiary of Glaukos Corporation.

Polymorph

Series A in 2015
Polymorph powers the monetization infrastructure for modern enterprises. Polymorph is a white-label SaaS monetization platform for publishers to maximize revenue, reduce costs and deliver better ad experiences.The Polymorph platform offers end-to-end ad serving stack, yield optimization tools, APIs, access to demand on server-side and self-serve workflows. Modern enterprises who want to monetize with advertising choose our customizable and developer friendly platform as it aligns with their needs/strategies. The company was founded in 2013 and is based in San Francisco, California.

Wiser Solutions

Series A in 2015
Wiser is the leading provider of actionable data for better decisions. Wiser collects and analyzes online and in-store data with unmatched speed, scale and accuracy. The Wiser platform then blends these insights with advanced workflow software to drive business value for brands and retailers. Using a unique combination of data science and human validation, Wiser offers integrated solutions for every aspect of retail, all in one place.

Gynesonics

Venture Round in 2015
Gynesonics, Inc. is a healthcare company specializing in the development of minimally invasive solutions for symptomatic uterine fibroids in women. The company offers the Sonata System, which utilizes sonography-guided transcervical fibroid ablation to treat these conditions under intrauterine sonography guidance. Founded in 2005, Gynesonics is headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands. The company serves customers worldwide, focusing on providing advanced, incision-free treatment options for uterine conditions.

Autonomic Technologies

Series D in 2015
Autonomic Technologies, Inc. is a medical device company that focuses on the development and commercialization of therapies for the treatment of autonomic disorders, particularly severe headache. It develops ATI Neurostimulation System, a device that delivers low-level energy directly to the area of the SPG for the treatment of chronic cluster headache. The company was founded in 2007 and is based in Mountain View, California with additional offices in Germany and Switzerland.

Joyus

Series C in 2015
Joyus is a startup focused on transforming the online shopping experience by utilizing short-form videos to help consumers discover and purchase appealing products. The company offers a video shopping platform that features curated selections of apparel, beauty items, and lifestyle products. Each week, curators showcase their favorite finds, providing viewers with insights on how to utilize these items. Products are available for a limited time through the platform, facilitating easy purchasing. Joyus emphasizes the importance of sharing authentic enthusiasm for products, enabling users to share videos with friends across social media platforms. The platform not only informs consumers about the latest trends but also delivers expert tips and lifestyle content, creating an engaging shopping experience tailored primarily for women.

Autonomic Technologies

Series D in 2015
Autonomic Technologies, Inc. is a medical device company that focuses on the development and commercialization of therapies for the treatment of autonomic disorders, particularly severe headache. It develops ATI Neurostimulation System, a device that delivers low-level energy directly to the area of the SPG for the treatment of chronic cluster headache. The company was founded in 2007 and is based in Mountain View, California with additional offices in Germany and Switzerland.

The RealReal

Series D in 2015
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Aryaka

Series C in 2015
[Aryaka](http://www.aryaka.com)'s Global SD-WAN provides optimized, software-defined network connectivity and application acceleration to globally distributed enterprises. Aryaka’s services have over 10 million users across more than 4,000 sites. Leading brands such as Skullcandy, Air China, Freescale Semiconductor, and ThoughtWorks, as well as partners such as Microsoft Azure, AWS, Intelisys, and SK Broadband, have all chosen Aryaka for their enterprise-grade networking needs.

Pivot3

Series G in 2015
Pivot3 is a provider of software infrastructure services aimed at simplifying data center operations by integrating storage, compute, and network resources into a cohesive solution. The company offers Dynamic Hyperconverged Infrastructure and PCIe Flash Arrays that optimize resource utilization, ensure high availability, and support mission-critical applications. Pivot3’s technologies help organizations lower their IT infrastructure costs, enhance revenue generation, improve customer satisfaction, and boost employee productivity. With a diverse portfolio tailored for various applications such as server virtualization, data center consolidation, and disaster recovery, Pivot3 has established a significant global presence, deploying over 16,000 hyperconverged infrastructures and flash storage solutions across 53 countries. Its client base spans mid-sized firms to major corporations in sectors including energy, aerospace, logistics, telecommunications, and retail. Through partnerships with technology and system integration firms, Pivot3 is committed to advancing smart IT infrastructures that pave the way for the future of software-defined data centers.

Invuity

Private Equity Round in 2015
Invuity, Inc. is a medical technology company specializing in the development and marketing of illuminated surgical devices in the United States and Asia. Utilizing its intelligent photonics technology platform, Invuity creates both single-use and reusable devices that enhance visibility during surgeries. Its product offerings include various illuminated retractor systems and handheld illuminators designed for a range of surgical applications, including breast, orthopedic, spine, cardiothoracic, and gynecological procedures. The BriteField Port System and BriteField McCulloch retractor are notable products that facilitate illumination and visualization during minimally invasive surgeries. Invuity sells its devices through a network of direct sales representatives and independent agents, as well as directly to hospitals and surgeons. Founded in 2004 and headquartered in San Francisco, California, Invuity was previously known as Spotlight Surgical, Inc. and has been operating as a subsidiary of Stryker Corporation since 2018.

Obalon Therapeutics

Series D in 2015
Obalon Therapeutics, Inc. is a medical device company headquartered in Carlsbad, California, specializing in the development and commercialization of innovative devices for obesity treatment. The company is known for its Obalon Balloon System, which features a swallowable capsule containing an inflatable balloon that aids in weight loss for individuals with obesity. This system includes the Obalon Navigation System, a console that uses hardware and software to track the balloon's placement, and the Obalon Touch Inflation Dispenser, a semi-automated device for inflating the balloon after placement. Additionally, it provides a disposable canister filled with gas for inflation. Founded in 2008, Obalon has established itself as a leader in gastric balloon technology, emphasizing collaboration with clinicians to enhance treatment outcomes while prioritizing safety and performance. As of early 2020, the company operated three retail treatment centers in California.

Welltok

Series D in 2015
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, that specializes in consumer activation within the healthcare sector. Founded in 2009, Welltok provides a health optimization platform that connects health plans, employers, providers, and public entities with consumers by offering personalized guidance and incentives for health improvement. The platform utilizes a large consumer database and machine learning to enhance audience engagement in healthy activities. By facilitating targeted actions, Welltok enables organizations to foster meaningful connections with individuals, encouraging them to take purposeful steps towards optimizing their health and wellbeing.

Sera Prognostics

Series B in 2015
Sera Prognostics, Inc. is a biotechnology company based in Salt Lake City, Utah, founded in 2008. The company specializes in developing diagnostic tests aimed at predicting a woman's individualized risk of premature birth, preeclampsia, and other pregnancy-related complications. By utilizing proprietary biomarkers, Sera Prognostics seeks to address the significant economic and healthcare challenges associated with premature births, impacting infants, families, and society at large. The company has licensed advanced serum proteomics technology and innovative peptides from Brigham Young University and the University of Utah to support its research and development efforts.

Cuyana

Venture Round in 2015
Cuyana, Inc. is a fashion brand based in San Francisco, California, focused on creating high-quality clothing, bags, small leather goods, and accessories. Founded in 2011, the company promotes the philosophy of "fewer, better things," emphasizing timeless design and durability. Cuyana sources its materials from the highest quality suppliers, ensuring that its products are crafted to last a lifetime. The company operates an online platform for direct sales to customers, which allows it to offer luxury items at attainable prices. In addition to its online presence, Cuyana maintains showrooms in various locations, including Palo Alto, New York City, Pacific Palisades, and Venice, Italy, where customers can experience the brand firsthand.

Knotch

Venture Round in 2015
Knotch, Inc. is an independent provider of real-time intelligence focused on digital marketing, headquartered in San Francisco, California. Founded in 2012, Knotch offers a content intelligence platform that integrates performance data with consumer sentiment. This platform enables brands to connect their content strategies to specific business outcomes by providing comprehensive data collection, analysis, and optimization capabilities. Marketers can utilize Knotch's intelligence suite to gain real-time insights, benchmark their efforts, and enhance both owned and paid content strategies. By facilitating a better understanding of content performance, Knotch aims to support brands in effectively planning, measuring, and optimizing their marketing initiatives.

InVisage Technologies

Series F in 2014
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

PMV Pharmaceuticals

Series A in 2014
PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

Restoration Robotics

Series C in 2014
Restoration Robotics is a privately held medical device company focused on advancing hair transplantation technology. The company has developed the ARTAS™ System, an innovative image-guided platform that facilitates follicular unit extraction. This system is notable for being the only computer-assisted, physician-controlled robotic solution for harvesting hair follicles, which enhances the precision and efficiency of the hair restoration process. By combining cutting-edge robotics with medical expertise, Restoration Robotics aims to improve outcomes for patients seeking hair restoration solutions.

Pivot3

Series E in 2014
Pivot3 is a provider of software infrastructure services aimed at simplifying data center operations by integrating storage, compute, and network resources into a cohesive solution. The company offers Dynamic Hyperconverged Infrastructure and PCIe Flash Arrays that optimize resource utilization, ensure high availability, and support mission-critical applications. Pivot3’s technologies help organizations lower their IT infrastructure costs, enhance revenue generation, improve customer satisfaction, and boost employee productivity. With a diverse portfolio tailored for various applications such as server virtualization, data center consolidation, and disaster recovery, Pivot3 has established a significant global presence, deploying over 16,000 hyperconverged infrastructures and flash storage solutions across 53 countries. Its client base spans mid-sized firms to major corporations in sectors including energy, aerospace, logistics, telecommunications, and retail. Through partnerships with technology and system integration firms, Pivot3 is committed to advancing smart IT infrastructures that pave the way for the future of software-defined data centers.

Stellar Loyalty

Series A in 2014
Stellar Loyalty Inc. specializes in providing cloud-based customer loyalty and engagement solutions. Founded in 2014 and headquartered in Foster City, California, with additional offices in Manila, Philippines, Stellar Loyalty integrates mobile and big data technologies to enhance customer interactions. The company’s platform enables brands to recognize, engage, and reward loyal customers by connecting loyalty programs with point-of-sale, marketing, and customer relationship management systems. Their offerings include advanced features such as calculations, business rules, segmentations, and predictive analytics, which together facilitate a seamless experience across digital, physical, and human interactions. Stellar Loyalty aims to enhance consumer experiences by delivering personalized value and recognition to customers. The company was acquired by Cheetah Digital in 2018.

Braze

Series B in 2014
Braze is a comprehensive customer engagement platform that powers relevant and memorable experiences between consumers and the brands they love. Context underpins every Braze interaction, helping brands foster human connection with consumers through interactive conversations across channels that deliver value quickly and continuously. The company was named a Leader in the 2019 Gartner Magic Quadrant for Mobile Marketing Platforms and was recognized as one of Inc Magazine's 2019 Best Workplaces. Braze is headquartered in New York with offices in Chicago, London, San Francisco, and Singapore. Learn more at braze.com.

OPAL

Series A in 2014
Opal Labs Inc. operates a marketing collaboration platform designed for modern marketing teams. The platform enables organizations to plan, create, view, edit, and approve brand marketing content effectively. By facilitating alignment on strategy and streamlining the review process, Opal enhances content creation and distribution. Its intuitive interface connects various information and content, breaking down silos and reducing complexity within teams. Founded in 2009 and headquartered in Portland, Oregon, Opal focuses on improving collaboration among marketing professionals to achieve successful campaign outcomes.

Pivot3

Series E in 2014
Pivot3 is a provider of software infrastructure services aimed at simplifying data center operations by integrating storage, compute, and network resources into a cohesive solution. The company offers Dynamic Hyperconverged Infrastructure and PCIe Flash Arrays that optimize resource utilization, ensure high availability, and support mission-critical applications. Pivot3’s technologies help organizations lower their IT infrastructure costs, enhance revenue generation, improve customer satisfaction, and boost employee productivity. With a diverse portfolio tailored for various applications such as server virtualization, data center consolidation, and disaster recovery, Pivot3 has established a significant global presence, deploying over 16,000 hyperconverged infrastructures and flash storage solutions across 53 countries. Its client base spans mid-sized firms to major corporations in sectors including energy, aerospace, logistics, telecommunications, and retail. Through partnerships with technology and system integration firms, Pivot3 is committed to advancing smart IT infrastructures that pave the way for the future of software-defined data centers.

Splice Machine

Series B in 2014
Splice Machine is a data platform that offers offline, and batch analysis, and powers intelligent applications for operational workflows. Splice Machine is disrupting the $30 billion traditional database world with the open-source dual-engine RDBMS for mixed operational and analytical workloads, powered by Apache Hadoop and Apache Spark. The Splice Machine RDBMS executes operational workloads on Apache HBase® and analytical workloads on Apache Spark. Splice Machine makes it easy to develop and create modern, real-time, scalable applications, or to offload operational and analytical workloads from expensive Oracle, Teradata, and Netezza systems. Typical use cases are ETL, operational reporting, or real-time applications.

Gynesonics

Debt Financing in 2014
Gynesonics, Inc. is a healthcare company specializing in the development of minimally invasive solutions for symptomatic uterine fibroids in women. The company offers the Sonata System, which utilizes sonography-guided transcervical fibroid ablation to treat these conditions under intrauterine sonography guidance. Founded in 2005, Gynesonics is headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands. The company serves customers worldwide, focusing on providing advanced, incision-free treatment options for uterine conditions.

Cidara Therapeutics

Series A in 2014
Cidara Therapeutics is a biotechnology company based in San Diego, California, dedicated to the discovery, development, and commercialization of innovative anti-infective therapies. The company's lead product candidate, rezafungin acetate, is an antifungal agent from the echinocandin class designed to treat and prevent serious invasive fungal infections, such as candidemia and invasive candidiasis, which carry high mortality rates. In addition to its antifungal efforts, Cidara is advancing its Cloudbreak platform, which focuses on developing antiviral Fc-conjugates aimed at preventing and treating viral infections, including influenza, RSV, HIV, and coronaviruses. Founded in 2012, Cidara Therapeutics has positioned itself as a key player in addressing life-threatening illnesses, particularly those that pose challenges due to immune system deficiencies.

Benvenue Medical

Series E in 2014
Benvenue Medical, Inc. specializes in the design, manufacturing, and marketing of minimally invasive expandable implant systems for treating spinal disorders, specifically vertebral compression fractures and degenerative disc diseases. The company offers products such as the Kiva system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer – C system, aimed at treating various types of pathological vertebral compression fractures. Additionally, Benvenue Medical has introduced the Luna 3D, an expandable interbody fusion system designed for use in minimally invasive, mini-open, or open surgical procedures. Established in 2004 and headquartered in Santa Clara, California, the company serves a diverse customer base in the United States, Canada, Belgium, France, and Germany.

Victorious

Series A in 2014
Victorious empowers creators to distribute all of their multimedia content in their own apps, interact more deeply and directly with their fan communities, and unlock new revenue streams. The company was founded in 2013 and is based in Santa Monica, California.

Aryaka

Series C in 2014
[Aryaka](http://www.aryaka.com)'s Global SD-WAN provides optimized, software-defined network connectivity and application acceleration to globally distributed enterprises. Aryaka’s services have over 10 million users across more than 4,000 sites. Leading brands such as Skullcandy, Air China, Freescale Semiconductor, and ThoughtWorks, as well as partners such as Microsoft Azure, AWS, Intelisys, and SK Broadband, have all chosen Aryaka for their enterprise-grade networking needs.

Apteligent

Series C in 2014
Apteligent, Inc. is a San Francisco-based company that specializes in mobile application intelligence solutions. Originally founded as Crittercism in 2010, the company rebranded in 2016 and has since developed a platform that provides real-time data collection and reporting tools to enhance mobile application performance. Apteligent's offerings include Userflows, which connect user experiences to business metrics; a Crash Reporting solution that identifies and monitors application errors; and Service Monitoring for analyzing performance metrics related to services and APIs. The platform supports various mobile operating systems, including iOS, Android, and Windows Phone, and caters to a diverse range of industries such as finance, retail, and gaming. Apteligent’s solutions enable businesses, developers, and IT operations to quickly identify and resolve application issues, ultimately improving app reliability and user satisfaction. The company operates as a subsidiary of VMware, Inc.

The RealReal

Series C in 2014
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Integrated Diagnostics

Series B in 2014
The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer's through blood tests that can monitor tens to hundreds of disease markers simultaneously. The company plans to develop a pipeline of game-changing diagnostic products that enable the diagnosis and prognosis of a variety of diseases. The company is based on the concept of a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes and other molecules.

Doximity

Series C in 2014
Doximity is a digital platform that serves as the largest professional medical network in the United States, connecting over 70 percent of U.S. physicians. Founded in 2011 and based in San Francisco, Doximity provides a suite of tools designed specifically for medical professionals, including physicians, nurse practitioners, physician assistants, and registered nurses. The platform facilitates secure communication among healthcare providers, enabling them to collaborate on patient care, conduct virtual visits, and stay informed about the latest medical news and research. Additionally, Doximity offers resources to help medical professionals manage their careers effectively.

InVisage Technologies

Series E in 2014
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

Damballa

Series E in 2014
Damballa specializes in advanced threat protection, focusing on the detection of active threats that evade conventional security measures. The company employs data science and machine learning techniques to identify successful infections and assess the risk posed by compromised devices, regardless of their operating system or threat vector. Damballa's solutions are designed to discover previously unknown threats, making the company a key player in cybersecurity. It safeguards nearly a billion endpoints across various sectors, including enterprises and major telecommunications providers. The firm also addresses issues related to botnet formation, providing essential safeguards against the misuse of Internet-enabled devices for harmful activities.

Polymorph

Seed Round in 2014
Polymorph powers the monetization infrastructure for modern enterprises. Polymorph is a white-label SaaS monetization platform for publishers to maximize revenue, reduce costs and deliver better ad experiences.The Polymorph platform offers end-to-end ad serving stack, yield optimization tools, APIs, access to demand on server-side and self-serve workflows. Modern enterprises who want to monetize with advertising choose our customizable and developer friendly platform as it aligns with their needs/strategies. The company was founded in 2013 and is based in San Francisco, California.

DataRPM

Series A in 2014
DataRPM Corporation develops a cognitive data science platform that automates machine learning for enterprises, both on-cloud and on-premise. The company's flagship offering, the Cognitive Predictive Maintenance (CPdM) platform, is designed to support industries in managing predictive maintenance within the industrial Internet of Things. This platform connects to data lakes and conducts multiple machine learning experiments to identify patterns, anomalies, and influencing factors, ultimately creating an ensemble of predictive models. DataRPM serves a global clientele, including Fortune 500 companies, assisting them in areas such as predictive maintenance, product recommendations, and churn predictions. Founded in 2011 and headquartered in Redwood City, California, DataRPM also has offices in the United Kingdom and Bengaluru, India. The company operates as a subsidiary of Progress Software Corporation.

Grokker

Series A in 2014
Grokker Inc. operates an online fitness training platform that offers a comprehensive range of videos focused on fitness, yoga, and cooking. Founded in 2012 and based in San Jose, California, the platform allows users to access thousands of instructional videos taught by experts in various disciplines, including cooking styles from around the world, yoga practices for different needs, and various fitness regimens. Grokker emphasizes a holistic approach to workplace wellness, providing an extensive library of over 3,700 videos that cover exercise, mindfulness, nutrition, finance, and sleep. With contributions from more than 130 master experts, Grokker aims to foster a supportive community that enhances employee well-being and engagement across various locations.

Invuity

Series E in 2014
Invuity, Inc. is a medical technology company specializing in the development and marketing of illuminated surgical devices in the United States and Asia. Utilizing its intelligent photonics technology platform, Invuity creates both single-use and reusable devices that enhance visibility during surgeries. Its product offerings include various illuminated retractor systems and handheld illuminators designed for a range of surgical applications, including breast, orthopedic, spine, cardiothoracic, and gynecological procedures. The BriteField Port System and BriteField McCulloch retractor are notable products that facilitate illumination and visualization during minimally invasive surgeries. Invuity sells its devices through a network of direct sales representatives and independent agents, as well as directly to hospitals and surgeons. Founded in 2004 and headquartered in San Francisco, California, Invuity was previously known as Spotlight Surgical, Inc. and has been operating as a subsidiary of Stryker Corporation since 2018.

Welltok

Series C in 2014
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, that specializes in consumer activation within the healthcare sector. Founded in 2009, Welltok provides a health optimization platform that connects health plans, employers, providers, and public entities with consumers by offering personalized guidance and incentives for health improvement. The platform utilizes a large consumer database and machine learning to enhance audience engagement in healthy activities. By facilitating targeted actions, Welltok enables organizations to foster meaningful connections with individuals, encouraging them to take purposeful steps towards optimizing their health and wellbeing.

Totango

Series B in 2014
Totango, Inc. is a company that specializes in developing an enterprise-grade customer success platform aimed at enhancing customer engagement and loyalty. Founded in 2010 and headquartered in Redwood City, California, Totango's platform allows businesses to consolidate customer data, monitor changes in customer health, and engage proactively with clients. Its offerings include the Customer Success Centre for enhancing engagement, Zoe for measuring enterprise impact, and DNA-CX for real-time customer context. The solutions address various aspects of customer success, including onboarding, adoption, renewal, and escalation. By simplifying the complexities of managing customer relationships, Totango helps companies increase customer lifetime value and drive predictable revenue growth. Totango operates as a subsidiary of Totango Ltd.

Crowdpac

Seed Round in 2014
Crowdpac, Inc. is a non-partisan political technology company that provides an online platform aimed at enhancing political participation in the United States. Founded in 2013 and based in Palo Alto, California, Crowdpac compiles essential information about political candidates, including their funding sources, positions on key issues, voting behavior, and past activities, into accessible candidate pages. Users can explore various issues such as healthcare, immigration, gender equality, and environmental policies, allowing them to find and support candidates that align with their priorities. Additionally, Crowdpac offers crowdfunding tools to empower candidates, organizations, and citizens to raise funds for political initiatives without relying on large donors or special interests. As of November 2019, Crowdpac operates as a subsidiary of Prytany.

Spredfast

Series D in 2014
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Khoros

Series D in 2014
Khoros is a software company that specializes in customer engagement solutions, providing a centralized cloud-based platform designed to enhance digital customer experiences. Its platform allows businesses to manage social media, monitor customer interactions, and scale their social marketing and customer service efforts. By facilitating millions of conversations, Khoros helps brands make informed decisions through data insights. The company aims to turn isolated knowledge into valuable enterprise insights, fostering stronger connections between businesses and their customers while anticipating customer needs to drive sales, loyalty, and innovation.

Flurry

Series D in 2013
Flurry, Inc. is a provider of mobile application analytics and advertising solutions, enabling businesses to build, measure, advertise, and monetize applications. Founded in 2005 and headquartered in San Francisco, with additional offices in New York, London, and Mumbai, Flurry offers a suite of products designed to enhance user engagement and drive revenue. Flurry Analytics allows over 125,000 companies to track consumer interactions across more than 400,000 applications, providing insights into audience reach, retention, and conversions. The platform features AppSpot, which delivers targeted advertisements to optimize clicks and revenue, and AppCircle, which helps organizations grow their application audience. Additionally, Flurry Personas segments consumers by shared interests, while Flurry Marketplace connects publishers to advertisers through a streamlined SDK integration. Flurry operates as a subsidiary of Yahoo! Inc. since August 2014.

Aria Systems

Series D in 2013
Proven by the world's most demanding enterprises, including AAA NCNU, Constant Contact, Falck, Hootsuite, Pitney Bowes, Audi, Adobe, Telekom Denmark, Philips, Roku, and VMware, Aria helps enterprises grow their recurring revenue businesses. Aria helps clients take advantage of each customer-driven event − known as revenue moments − with agile billing, active customer engagement, and the rapid development of new products and services. With Aria's end-to-end active monetization platform, global brands can get to market faster with a wider variety of products and services, while maximizing customer satisfaction, retention, and lifetime value.

GAIN Fitness

Angel Round in 2013
GAIN Fitness, Inc. specializes in developing a fitness application designed for iPhone users that creates personalized workout plans tailored to individual body types, fitness goals, and lifestyle factors. Incorporated in 2009 and based in San Francisco, California, the application utilizes exercise science to generate dynamic training programs, helping users optimize their fitness routines and adapt to changing schedules. It features an extensive database of over 750 exercises and incorporates social elements and game mechanics to enhance user motivation. GAIN Fitness also collaborates with personal trainers and equipment retailers to offer interactive multimedia fitness packages, expanding its reach within the fitness market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.